Trial Profile
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2017
Price :
$35
*
At a glance
- Drugs Olopatadine (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Alcon
- 16 Nov 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2010 Planned end date changed from 1 Jan 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.